MONIQUE BRUNELLE: Open Payments
NPI 1770368532 · BOLTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 75 payments from 14 companies in 2025. Trend: 2023 $397 · 2024 $1,447 · 2025 $1,645
Food & beverage: $1,581Education: $65
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $461 |
| Novo Nordisk Inc | 18 | $392 |
| ABBVIE INC. | 13 | $237 |
| Lilly USA, LLC | 5 | $117 |
| Biogen, Inc. | 3 | $74 |
| Amneal Pharmaceuticals LLC | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: AIRSUPRA, Ozempic, BREZTRI, Rybelsus, MOUNJARO, QULIPTA, UBRELVY, SKYCLARYS.
Industry payments across CT — which companies pay providers there.
